semaglutide patent novo nordisk Takes Telehealth Company to Court Over Knockoffs The upcoming expiry of the

Transformed lives through weight loss and glucose control, contrasted with lives forever changed by vision loss

After PS matching, no differences were observed in age, sex, height, weight, BMI, eGFR, smoking status, alcohol consumption, or the number of health screening examinations among the three groups

Discussion The main objective of these studies is to evaluate the therapeutic potential of GLP-1 agonists in MS management

, GLP-1 (GLP-1)

Methods We used data from nationwide registers in Sweden to perform separate analyses for all patients with type 2 diabetes who filled a first prescription of a GLP-1 receptor agonist or an SGLT2 inhibitor between 2017 and 2021

November 24, 2025